Trader Talk

IPOs all wet as tidal wave of new offerings loom

Traders on the floor of the New York Stock Exchange.
Getty Images

Over the last two days, initial public offerings (IPOs) have hit a speed bump--again. The market has absorbed more disappointing pricings ahead of what promises to be a huge week.

Pipe maker Advanced Drainage Systems priced 14.5 million shares at $16.00, well below the price talk of $17—$19; biotech firm Ocular Therapeutics priced 5.0 million share at $13.00, well below the price talk of $14—$16. Orion Engineered Carbons (OEC), a maker of carbon black, priced 19.5 million shares at $18, way below the price talk of $21—$24.

However, El Pollo Loco priced 7.1 million shares at $15.00, the high end of the price talk of $13—$15. This is in the hot fast-casual restaurant space, a space Chipotle has inhabited successfully.

Of the 8 IPOs that have priced in the past 36 hours, 6 have priced below the price talk, 1 at the low end of the price talk, and 1 at the high end. That is a disappointment.

Pisani's market eyes IPOs

The disappointment presages what is shaping up to be a monster week for IPOs. There are 22 companies looking to raise $6.6 billion, and half of that money is one company: Synchrony (CYK). The firm seeking to raise 125 million shares at $23$26. Do the math here: that's a $3 billion deal! The average IPO is $100$200 million.

This is the old GE Capital. They're only floating a small part of it (15 percent) but even that part is huge. It's a huge consumer finance company, the largest provider of private label credit cards in the U.S. But beware: they are planning to spin off the rest of it in 2015, so a LOT of stock will be coming in the next year.

And, of course, the usual plethora of biotech.

Why are banks dumping a HUGE pile of IPOs in a week where maybe 40 percent of the Street is on vacation? Because they can. I'm not being flippant: the object is to get stuff out the door while the market is still strong.

--By CNBC's Bob Pisani